Research ArticleOriginal Research
Risk Factors for Methicillin-Resistant Staphylococcal aureus Skin and Soft Tissue Infections Presenting in Primary Care: A South Texas Ambulatory Research Network (STARNet) Study
Michael L. Parchman and Abel Munoz
The Journal of the American Board of Family
Medicine July 2009, 22 (4) 375-379; DOI: https://doi.org/10.3122/jabfm.2009.04.090003

References
- ↵Klevens RM, Morrison MA, Nadel J, et al. Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA 2007; 298: 1763–71.
- ↵Ferry T, Etienne J. Community acquired MRSA in Europe. BMJ 2007; 335: 947–8.
- ↵David M, Glikman D, Crawford S, et al. What is community-associated methicillin-resistant Staphylococcus aureus? J Infect Dis 2008; 197: 1235–43.
- ↵Zetola N, Fancis J, Nuermberger W. Community-acquired methicillin-resistant Staphylococcus aureus: an emerging threat. Lancet Infect Dis 2005; 5: 275–86.
- ↵Hersh A, Chambers H, Maselli J, Gonzales R. National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections. Arch Intern Med 2008; 168: 1585–91.
- ↵Moran GJ, Krishnadasan A, Gorwitz RJ, et al. Methicillin-resistant S. aureus infections among patients in the emergency department. N Eng J Med 2006; 355: 666–74.
- ↵
- ↵Gorwitz RJ, Kruszon-Moran D, McAllister SK, et al. Changes in the prevalence of Staphylococcus aureus nasal colonization in the United States. J Infect Dis 2008; 197: 1226–34.
- Flynn N, Cohen SH. The continuing saga of MRSA. J Infect Dis 2008; 197: 1217–9.
- ↵Proctor RA. Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infections. Clin Infect Dis 2008; 46: 584–93.
In this issue
Risk Factors for Methicillin-Resistant Staphylococcal aureus Skin and Soft Tissue Infections Presenting in Primary Care: A South Texas Ambulatory Research Network (STARNet) Study
Michael L. Parchman, Abel Munoz
The Journal of the American Board of Family
Medicine Jul 2009, 22 (4) 375-379; DOI: 10.3122/jabfm.2009.04.090003
Risk Factors for Methicillin-Resistant Staphylococcal aureus Skin and Soft Tissue Infections Presenting in Primary Care: A South Texas Ambulatory Research Network (STARNet) Study
Michael L. Parchman, Abel Munoz
The Journal of the American Board of Family
Medicine Jul 2009, 22 (4) 375-379; DOI: 10.3122/jabfm.2009.04.090003
Jump to section
Related Articles
- No related articles found.
Cited By...
- Treatment Failure and Costs in Patients With Methicillin-Resistant Staphylococcus aureus (MRSA) Skin and Soft Tissue Infections: A South Texas Ambulatory Research Network (STARNet) Study
- Management of Skin and Soft Tissue Infections in Community Practice Before and After Implementing a "Best Practice" Approach: An Iowa Research Network (IRENE) Intervention Study
- Prevalence, Severity, and Treatment of Community-Acquired Methicillin-Resistant Staphylococcus Aureus (CA-MRSA) Skin and Soft Tissue Infections in 10 Medical Clinics in Texas: A South Texas Ambulatory Research Network (STARNet) Study
- Improving the Management of Skin and Soft Tissue Infections in Primary Care: A Report From State Networks of Colorado Ambulatory Practices and Partners (SNOCAP-USA) and the Distributed Ambulatory Research in Therapeutics Network (DARTNet)
- A Logic Model Framework for Evaluation and Planning in a Primary Care Practice-based Research Network (PBRN)
- Card Studies for Observational Research in Practice
- Trimethoprim-Sulfamethoxazole or Clindamycin for Community-Associated MRSA (CA-MRSA) Skin Infections
- System-Based Participatory Research in Health Care: An Approach for Sustainable Translational Research and Quality Improvement
- Fourth Journal of the American Board of Family Medicine Practice-based Research Theme Issue
- Practice-based Research is Community Engagement